News
-
-
PRESS RELEASE
Update: ZenaTech Announces Acquisition of Warehouse Software Companies for Integration with AI Drone Solution for Automated Inventory Management
ZenaTech acquires warehouse software companies to integrate with AI drone solution for automated inventory management, expanding SaaS solutions and customer base to drive operational efficiencies and cost savings -
PRESS RELEASE
Angeline Pompei Launches The Bilingual Book Company With Bilingual Audiobooks for Kids and Language Students
The Bilingual Book Company offers bilingual audiobooks for kids with line-by-line translations to make language learning enjoyable and part of daily activities. Visit TheBilingualBookCompany.com to explore their collection -
-
PRESS RELEASE
4finance Holding S.A. reports results for the nine months ending 30 September 2024
4finance Holding S.A. reports solid financial results for the nine months ending 30 September 2024, with net profit of €37.6 million and Adjusted EBITDA of €116.2 million. The company shows stable online loan issuance and growth opportunities in the UK and Mexico -
PRESS RELEASE
Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets
Mainz Biomed and Thermo Fisher Scientific sign a collaboration agreement for the development of next generation colorectal cancer screening product for global markets -
-
PRESS RELEASE
Dr. JD Dudum of Dudum Chiropractic Co-Authors Study Demonstrating the Effectiveness of His Non-Surgical Spinal Decompression Technique
Study published in The Journal of Contemporary Chiropractic highlights effectiveness of nonsurgical spinal decompression therapy for lower back pain and herniated discs by Dr. JD Dudum of Dudum Chiropractic, Walnut Creek -
-
PRESS RELEASE
Xenetic Biosciences, Inc. Presents Positive Data Demonstrating DNase I Significantly Improves Efficacy of Anti-CTLA-4 Immune Checkpoint Blockade in Preclinical Colorectal Carcinoma Models
Positive preclinical data on systemic DNase I combined with CTLA-4 antibody presented at SITC 2024, targeting NETs to enhance antitumor immunity and generate immunological memory in MSS/MMRp CRC tumors
